NCT05926739

Brief Summary

Evaluate the evolution of locomotor abilities in patients treated with functional electrostimulation and biofeedback (PHENIX LIBERTY VIVALTIS device) for musculoskeletal disorders of the knee and spine. Does the use of the medical device in the treatment of musculoskeletal disorders lead to an improvement ? Participants will use the medical device, which provides electrical stimulation, biofeedback and pressure biofeedback to re-educate the muscles of the knee and spine area and

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 22, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 3, 2023

Completed
1.1 years until next milestone

Study Start

First participant enrolled

August 19, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 18, 2024

Completed
Last Updated

December 24, 2024

Status Verified

December 1, 2024

Enrollment Period

4 months

First QC Date

June 22, 2023

Last Update Submit

December 19, 2024

Conditions

Keywords

Electrical stimulationBiofeedbackKneeLow Back Pain

Outcome Measures

Primary Outcomes (2)

  • Mean change in Lower Extremity Functional Scale (LEFS) score on the impact of locomotor disorders of the knee

    The Lower Extremity Functional Scale (LEFS) is used by physiotherapists and occupational therapists in many clinical settings. It is an English-language measurement tool that collects psychometric data and assesses the functional status of the lower limbs. It consists of 20 questions on the level of difficulty experienced during everyday activities.

    At Day 0 and Week 11 (at the end visit within the week after the 12th seance)

  • Mean change in the Oswestry Disability Index (ODI) score for the impact of locomotor disorders of the spine.

    The ODI will be used to assess the disability caused by Lower Back Pain (LBP) The Oswestry Disability Index (ODI), a patient-completed questionnaire that gives a subjective percentage score of the level of function (disability) in activities of daily living in people undergoing rehabilitation after low back pain. The questionnaire examines the level of disability in 10 activities of daily living. Each item consists of 6 statements rated from 0 to 5. With 0 indicating the lowest level of disability and 5 the highest, the total score is calculated as a percentage, with 0% indicating no disability and 100% indicating the highest level of disability.

    At Day 0 and Week 11 (at the end visit within the week after the 12th seance)

Secondary Outcomes (13)

  • Change in patients' visual analog scale (VAS) pain scores for knee pain and/or spine pain at rest and on palpation

    At Day 0 and Week 11 (at the end visit within the week after the 12th seance)

  • Trends in consumption of painkillers and anti-inflammatories

    At Day 0 and Week 11 (at the end visit within the week after the 12th seance)

  • Changes in the rate of improvement of hypertonia of the concerned area (knee or spine) through measurement of myoelectric activity

    At Day 0 and Week 11 (at the end visit within the week after the 12th seance)

  • Changes in the rate of improvement of hypertonia of the concerned area (knee or spine) through Oxford Grading Scale

    At Day 0 and Week 11 (at the end visit within the week after the 12th seance)

  • Changes in the rate of improvement in awakening and muscle strengthening through Oxford grading scale

    At Day 0 and Week 11 (at the end visit within the week after the 12th seance)

  • +8 more secondary outcomes

Study Arms (1)

Standard of care plus additional questionaire

OTHER

As part of this clinical investigation, the medical device under investigation is used in accordance with its usual use, and the patient's therapeutic procedure includes additional, non-invasive procedures. These additional procedures relate to the addition of an endof- life visit and validated questionnaires assessing functional deficiencies and impact on daily life.

Device: Electrical stimulation and biofeedback with Phenix Liberty medical device

Interventions

12 sessions of electrical stimulation and biofeedback performed between 6 and 8 weeks at regular intervals according to a schedule drawn up by the physiotherapist. The patient will undergo 12 therapeutic functional reeducation sessions, at regular intervals according to a schedule drawn up by the physiotherapist, during which the PHENIX LIBERTY device may be used. The patients will complete questionnaires at the end of the care. Overall, the functional rehabilitation sessions will include muscle testing, electrostimulation and biofeedback. The follow up will be conduct as follow : * 12 sessions between 6 and 8 weeks * 1 end visit, within the week after the 12th session

Standard of care plus additional questionaire

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (between 18 and 65 years of age);
  • Patient presenting at least one of the following symptoms related to a locomotor disorder of the knee and/or spine: pain, hypertonia, amyotrophy, mobility restriction, muscle weakness, reduction or loss of motor control, reduction in motor pattern, trophic anomaly;
  • Patient able to make himself available to attend sessions regularly and is confident of being able to complete all sessions; ;
  • Patient who has signed the study participation consent form;y;
  • Patient physically and mentally willing and able, according to the investigator's judgment at the time of recruitment, to perform the procedures under study;
  • Patient with social security coverage.

You may not qualify if:

  • Patients with Stroke, Alzheimer's, multiple sclerosis, peripheral nervous system disorders, spinal cord injury or with cognitive and/or behavioural disorders likely, in the practitioner's judgement in the practitioner's judgement, interact with the self-assessment or biofeedback;
  • Patients with hypersensitivity to electrostimulation;
  • Patients with an implanted pacemaker or spinal cord pacemaker;
  • Patients who have renounced their liberty by administrative or judicial sentence, or under guardianship or limited judicial protection;
  • Patient unable to read or write French;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Human Physio

Nîmes, 30000, France

Location

MeSH Terms

Conditions

Musculoskeletal DiseasesLow Back Pain

Interventions

Electric StimulationBiofeedback, Psychology

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Physical StimulationInvestigative TechniquesMind-Body TherapiesComplementary TherapiesTherapeuticsBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesFeedback, Psychological

Study Officials

  • Mathias Willame

    Human Physio

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2023

First Posted

July 3, 2023

Study Start

August 19, 2024

Primary Completion

December 18, 2024

Study Completion

December 18, 2024

Last Updated

December 24, 2024

Record last verified: 2024-12

Locations